Intangible assets, net - Impairment loss (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Intangible assets, net | |||
| Total impairment loss | $ 3,291 | $ 90 | $ 416 |
| Selling, general and administrative expenses | |||
| Intangible assets, net | |||
| Total impairment loss | $ 223 | $ 90 | $ 376 |
| Goodwill, Impairment Loss, Statement of Income or Comprehensive Income [Extensible Enumeration] | Research and development expenses | Research and development expenses | Research and development expenses |
| Research and development expenses | |||
| Intangible assets, net | |||
| Total impairment loss | $ 3,068 | $ 0 | $ 40 |
| Goodwill, Impairment Loss, Statement of Income or Comprehensive Income [Extensible Enumeration] | Research and development expenses | Research and development expenses | Research and development expenses |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Indicates line item in statement of income or comprehensive income that includes impairment loss for goodwill. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|